Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cellsBo Li, Zhang Lei, Brain D Lichty, et al.
Oncoimmunology|October 2, 2013
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8<sup>+</sup> T-cell responses to anticancer vaccinesByram W Bridle, Derek Clouthier, Liang Zhang, et al.
Plos One|April 12, 2016
High Physiological Concentrations of Progesterone Reverse Estradiol-Mediated Changes in Differentiation and Functions of Bone Marrow Derived Dendritic CellsFangming Xiu, Varun C Anipindi, Philip V Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2005
Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopeniaNatalie Grinshtein, Teng-Chih Yang, Robin Parsons, et al.
Vaccine|March 17, 2018
Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancerMatthew J Atherton, Kyle B Stephenson, Jake K Nikota, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirusByram W Bridle, Jeanette E Boudreau, Brian D Lichty, et al.
Current Gene Therapy|October 28, 2005
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccinesZhou Xing, Michael Santosuosso, Sarah McCormick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK CellsKhalil Karimi, Jeanette E Boudreau, Katie Fraser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 7, 2007
Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cellsKhalil Karimi, Jeanette E Boudreau, Katie Fraser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTLLea Luketic, Jordan Delanghe, Paul T Sobol, et al.
Pageof 9